DocuSign Signs Off On Strong Quarter, Growth Remains Work in Progress

DocuSign (DOCU) shares rose after the company exceeded Q2 earnings with $0.92 EPS and $800.6M revenue, and raised its FY26 revenue outlook to $3.19B-$3.20B. JPMorgan maintained a Neutral rating, raising its price target to $80, citing balanced risk/reward and stabilizing growth as go-to-market execution improves. The firm emphasized that future valuation hinges on clearer GAAP profitability and the success of DocuSign's IAM product cycle, with long-term growth relying on expanding sales to existing clients and broader suite adoption amidst ongoing sales reorganization.

Analysis

DocuSign (DOCU) delivered a strong fiscal second quarter, exceeding consensus estimates with an EPS of $0.92 and revenue of $800.6 million, representing a 9% year-over-year growth. The positive performance was coupled with an upward revision of its fiscal 2026 revenue guidance to between $3.19 and $3.20 billion, surpassing the prior Street estimate. Despite these beats and the subsequent 4.58% share price increase, the sentiment from JPMorgan remains cautious. The firm maintained its Neutral rating while raising its price target to $80, citing a balanced risk-reward profile. The analysis suggests that while near-term growth is stabilizing due to improved go-to-market execution, significant challenges remain. Future growth is contingent on the company's ability to upsell and cross-sell its broader CLM and IAM product suite to its extensive installed base, as pandemic-era tailwinds have normalized. Key concerns tempering the outlook include the time required for the new IAM product cycle to impact the business mix, the need for clearer progress on GAAP profitability to justify the valuation, and potential near-term volatility in billings and revenue stemming from ongoing executive transitions and a sales reorganization.

Key Decisions for Investors

• Given the stabilizing growth and improved execution, investors with a long-term thesis may consider holding positions, but should recognize the balanced risk-reward profile highlighted by the Neutral rating.
• Monitor key performance indicators beyond top-line beats, specifically progress toward GAAP profitability and the adoption rate of the expanded CLM and IAM product suite, as these are the primary catalysts required for a potential valuation re-rating.
• Be prepared for potential short-term volatility in billings and revenue due to the ongoing sales reorganization and executive changes, which could present tactical trading opportunities or signal deeper operational challenges.